BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7527173)

  • 1. Complementation of human immunodeficiency virus type 1 vif mutants in some CD4+ T-cell lines.
    Hevey M; Donehower LA
    Virus Res; 1994 Sep; 33(3):269-80. PubMed ID: 7527173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
    Gabuzda DH; Lawrence K; Langhoff E; Terwilliger E; Dorfman T; Haseltine WA; Sodroski J
    J Virol; 1992 Nov; 66(11):6489-95. PubMed ID: 1357189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
    Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants.
    Reddy TR; Kraus G; Yamada O; Looney DJ; Suhasini M; Wong-Staal F
    J Virol; 1995 Jun; 69(6):3549-53. PubMed ID: 7745702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages.
    Gabuzda DH; Li H; Lawrence K; Vasir BS; Crawford K; Langhoff E
    J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):908-15. PubMed ID: 7519673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free transmission of Vif mutants of HIV-1.
    Fan L; Peden K
    Virology; 1992 Sep; 190(1):19-29. PubMed ID: 1529528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2.
    Michaels FH; Hattori N; Gallo RC; Franchini G
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1025-30. PubMed ID: 8280477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the cell-dependent replication potentials of human immunodeficiency virus type 1 vif mutants.
    Fujita M; Sakurai A; Doi N; Miyaura M; Yoshida A; Sakai K; Adachi A
    Microbes Infect; 2001 Nov; 3(13):1093-9. PubMed ID: 11709289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vif mutations on cell-free infectivity and replication of simian immunodeficiency virus.
    Park IW; Myrick K; Sodroski J
    J Acquir Immune Defic Syndr (1988); 1994 Dec; 7(12):1228-36. PubMed ID: 7965633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein.
    Madani N; Kabat D
    J Virol; 1998 Dec; 72(12):10251-5. PubMed ID: 9811770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis.
    Nascimbeni M; Bouyac M; Rey F; Spire B; Clavel F
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1945-50. PubMed ID: 9714242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    Borman AM; Quillent C; Charneau P; Dauguet C; Clavel F
    J Virol; 1995 Apr; 69(4):2058-67. PubMed ID: 7884851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
    Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.
    Chowdhury IH; Chao W; Potash MJ; Sova P; Gendelman HE; Volsky DJ
    J Virol; 1996 Aug; 70(8):5336-45. PubMed ID: 8764044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1.
    Sova P; Volsky DJ
    J Virol; 1993 Oct; 67(10):6322-6. PubMed ID: 8371360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent lack of trans-dominant negative effects of various vif mutants on the replication of HIV-1.
    Fujita M; Matsumoto S; Sakurai A; Doi N; Miyaura M; Yoshida A; Adachi A
    Microbes Infect; 2002 Oct; 4(12):1203-7. PubMed ID: 12467760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free HIV-1Zr6 vif mutants are defective in binding to peripheral blood mononuclear cells and in internalization.
    Nagashunmugam T; Friedman HM
    DNA Cell Biol; 1996 May; 15(5):353-61. PubMed ID: 8924209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells.
    Bouyac M; Rey F; Nascimbeni M; Courcoul M; Sire J; Blanc D; Clavel F; Vigne R; Spire B
    J Virol; 1997 Mar; 71(3):2473-7. PubMed ID: 9032385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors.
    Simm M; Pekarskaya O; Potash MJ; Volsky DJ
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):943-52. PubMed ID: 10890355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity.
    Sakai K; Ma XY; Gordienko I; Volsky DJ
    J Virol; 1991 Nov; 65(11):5765-73. PubMed ID: 1920615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.